Catherine Ramsey
Stock Analyst at Baird
(3.03)
# 1,247
Out of 4,829 analysts
49
Total ratings
35.14%
Success rate
4.15%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Ramsey
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
WAT Waters | Maintains: Outperform | $355 → $374 | $344.06 | +8.70% | 10 | May 7, 2025 | |
TWST Twist Bioscience | Maintains: Outperform | $54 → $44 | $30.82 | +42.76% | 7 | May 6, 2025 | |
RVTY Revvity | Maintains: Outperform | $127 → $125 | $91.25 | +36.99% | 5 | Apr 29, 2025 | |
ILMN Illumina | Maintains: Neutral | $127 → $90 | $75.76 | +18.80% | 5 | Mar 5, 2025 | |
NTRA Natera | Maintains: Outperform | $183 → $188 | $151.95 | +23.72% | 6 | Feb 28, 2025 | |
CSTL Castle Biosciences | Maintains: Outperform | $36 → $37 | $16.81 | +120.11% | 8 | Feb 28, 2025 | |
TMO Thermo Fisher Scientific | Maintains: Outperform | $695 → $665 | $403.13 | +64.96% | 2 | Nov 1, 2022 | |
A Agilent Technologies | Maintains: Outperform | $155 → $160 | $106.93 | +49.63% | 5 | Aug 17, 2022 | |
EXAS Exact Sciences | Maintains: Outperform | $90 → $75 | $51.63 | +45.26% | 1 | Aug 3, 2022 |
Waters
May 7, 2025
Maintains: Outperform
Price Target: $355 → $374
Current: $344.06
Upside: +8.70%
Twist Bioscience
May 6, 2025
Maintains: Outperform
Price Target: $54 → $44
Current: $30.82
Upside: +42.76%
Revvity
Apr 29, 2025
Maintains: Outperform
Price Target: $127 → $125
Current: $91.25
Upside: +36.99%
Illumina
Mar 5, 2025
Maintains: Neutral
Price Target: $127 → $90
Current: $75.76
Upside: +18.80%
Natera
Feb 28, 2025
Maintains: Outperform
Price Target: $183 → $188
Current: $151.95
Upside: +23.72%
Castle Biosciences
Feb 28, 2025
Maintains: Outperform
Price Target: $36 → $37
Current: $16.81
Upside: +120.11%
Thermo Fisher Scientific
Nov 1, 2022
Maintains: Outperform
Price Target: $695 → $665
Current: $403.13
Upside: +64.96%
Agilent Technologies
Aug 17, 2022
Maintains: Outperform
Price Target: $155 → $160
Current: $106.93
Upside: +49.63%
Exact Sciences
Aug 3, 2022
Maintains: Outperform
Price Target: $90 → $75
Current: $51.63
Upside: +45.26%